Literature DB >> 15094763

Signaling control of mRNA translation in cancer pathogenesis.

Eric C Holland1, Nahum Sonenberg, Pier Paolo Pandolfi, George Thomas.   

Abstract

The regulation of translation and the control of ribosome biogenesis are essential cellular processes whose impact on cell growth and proliferation is manifested at a number of specific levels. Disruption in one or more of the steps that control protein biosynthesis has been associated with alterations in the regulation of cell growth and cell cycle progression. Consistent with this, tumor suppressors and proto-oncogenes have been found to act on these functions and may therefore regulate malignant progression by affecting the protein synthetic machinery. Although many studies have correlated deregulation of protein biosynthesis with cancer, it remains to be established whether this process is necessary and/or sufficient for neoplastic transformation and metastasis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15094763     DOI: 10.1038/sj.onc.1207590

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  56 in total

1.  Novel 5'TOPmRNAs regulated by ribosomal S6 kinase are important for cardiomyocyte development: S6 kinase suppression limits cardiac differentiation and promotes pluripotent cells toward a neural lineage.

Authors:  LeeAnn Li; Shannon M Larabee; Shenglin Chen; Ladan Basiri; Seiji Yamaguchi; Asif Zakaria; G Ian Gallicano
Journal:  Stem Cells Dev       Date:  2012-02-08       Impact factor: 3.272

2.  Systematic identification and functional screens of uncharacterized proteins associated with eukaryotic ribosomal complexes.

Authors:  Tracey C Fleischer; Connie M Weaver; K Jill McAfee; Jennifer L Jennings; Andrew J Link
Journal:  Genes Dev       Date:  2006-05-15       Impact factor: 11.361

3.  Overexpression of eIF4F components in meningiomas and suppression of meningioma cell growth by inhibiting translation initiation.

Authors:  Janet L Oblinger; Sarah S Burns; Jie Huang; Li Pan; Yulin Ren; Rulong Shen; A Douglas Kinghorn; D Bradley Welling; Long-Sheng Chang
Journal:  Exp Neurol       Date:  2017-06-10       Impact factor: 5.330

Review 4.  Nucleolar adaptation in human cancer.

Authors:  Leonard B Maggi; Jason D Weber
Journal:  Cancer Invest       Date:  2005       Impact factor: 2.176

5.  Palmitoylation of oncogenic NRAS is essential for leukemogenesis.

Authors:  Benjamin Cuiffo; Ruibao Ren
Journal:  Blood       Date:  2010-03-03       Impact factor: 22.113

6.  Ras Suppresses TXNIP Expression by Restricting Ribosome Translocation.

Authors:  Zhizhou Ye; Donald E Ayer
Journal:  Mol Cell Biol       Date:  2018-09-28       Impact factor: 4.272

Review 7.  Pharmacotherapeutic management of pediatric gliomas : current and upcoming strategies.

Authors:  Trent R Hummel; Lionel M Chow; Maryam Fouladi; David Franz
Journal:  Paediatr Drugs       Date:  2013-02       Impact factor: 3.022

Review 8.  Posttranscriptional regulation of p53 and its targets by RNA-binding proteins.

Authors:  Jin Zhang; Xinbin Chen
Journal:  Curr Mol Med       Date:  2008-12       Impact factor: 2.222

9.  Regulation of mTORC1 signaling by Src kinase activity is Akt1-independent in RSV-transformed cells.

Authors:  Martina Vojtechová; Jolana Turecková; Dana Kucerová; Eva Sloncová; Jirí Vachtenheim; Zdena Tuhácková
Journal:  Neoplasia       Date:  2008-02       Impact factor: 5.715

10.  Rat Urinary Bladder Carcinogenesis by Dual-Acting PPARalpha + gamma Agonists.

Authors:  Martin B Oleksiewicz; Jennifer Southgate; Lars Iversen; Frederikke L Egerod
Journal:  PPAR Res       Date:  2009-01-28       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.